L-proline Activates Glutamate and Glycine Receptors in Cultured Rat Dorsal Horn Neurons
Overview
Pharmacology
Authors
Affiliations
The pharmacological actions of L-proline on excitatory and inhibitory amino acid receptors have been characterized under voltage-clamp conditions, using cultured dissociated neurons from the dorsal horn of the rat spinal cord. At a holding potential of -62 mV, millimolar concentrations of L-proline elicited an inward current that was partially antagonized by D-(-)-2-amino-5-phosphonopentanoic acid (APV), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and strychnine and was virtually abolished (97% block) by a combination of all three antagonists. Currents evoked by D-proline were abolished by strychnine alone. APV-, CNQX-, and strychnine-sensitive components of L-proline-evoked currents were isolated using various combinations of the three antagonists. These currents were identical to currents elicited by N-methyl-D-aspartate (NMDA), kainate, and glycine, respectively, with respect to antagonist specificity, reversal potential, and ionic permeability. The APV- and strychnine-sensitive currents also showed a time dependence similar to that of the currents elicited by NMDA and glycine. EC50 values could not be calculated, because the response did not saturate within the tested range of L-proline concentrations (0.3-50 mM). Estimates of relative potency were obtained, however, by comparison with responses elicited by selective agonists. The APV-sensitive, CNQX-sensitive, and strychnine-sensitive currents evoked by 10 mM L-proline were comparable in size to currents elicited by 15 microM NMDA, 5 microM kainate, and 30 microM glycine, respectively. L-Proline was found to elicit an increase in intracellular [Ca2+] that was dependent upon Ca2+ entry into the cell. These Ca2+ responses were enhanced by strychnine and partially antagonized by APV, CNQX, or Mg2+. Our results using dorsal horn neurons grown in culture indicate that L-proline is a weak agonist at strychnine-sensitive glycine receptors and at both NMDA and non-NMDA glutamate receptors. These observations should help in interpreting the confusing array of L-proline actions that have been described using more intact nervous system preparations. Furthermore, the ability of L-proline to stimulate Ca2+ entry after activation of excitatory amino acid receptors implicates L-proline as a potential endogenous excitotoxin.
Koshovyi O, Sepp J, Jakstas V, Zvikas V, Kireyev I, Karpun Y Int J Mol Sci. 2024; 25(15).
PMID: 39125862 PMC: 11311743. DOI: 10.3390/ijms25158292.
Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2.
Li H, Pike A, Lotsaris I, Chi G, Hansen J, Lee S Nat Commun. 2024; 15(1):5503.
PMID: 38951531 PMC: 11217458. DOI: 10.1038/s41467-024-48921-x.
Carvalho G, Chiareli R, Pedrazzi J, Silva-Amaral D, Batista da Rocha A, Oliveira-Lima O Neurochem Res. 2023; 49(1):170-183.
PMID: 37684384 DOI: 10.1007/s11064-023-04018-3.
L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke.
Carvalho G, Chiareli R, Marques B, Parreira R, Gil E, de Carvalho F Pharmacol Rep. 2023; 75(2):276-292.
PMID: 36719635 DOI: 10.1007/s43440-023-00451-x.
Zhao L, Yi R, Liu S, Chi Y, Tan S, Dong J PLoS One. 2023; 18(1):e0267064.
PMID: 36662735 PMC: 9858065. DOI: 10.1371/journal.pone.0267064.